NYSE$YCBD
cbdMD Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Paw CBD sales increased by 64% from the March 2020 quarter to the June 2020 quarter.
Paw CBD, cbdMD's pet CBD brand, experienced a 64% increase in net sales, growing from approximately $750,000 in the March 2020 quarter to approximately $1,229,000 in the June 2020 quarter.
- Paw CBD's sales increased by 64% from the March 2020 quarter to the June 2020 quarter.
- Paw CBD is trending at over a $7 million annualized run rate.
- cbdMD's direct-to-consumer (DTC) sales make up over 70% of the brand’s revenue.
- The company is focusing on cross-selling, customer retention and education, and will be rolling out Paw CBD subscription and reward programs shortly.
Headline financials
Revenue & EPS history
cbdMD · Revenue · Quarterly
$10.6M
Revenue by segment
cbdMD · $3.8M total across 1 segment · Q2 2026
- E-commerce sales$3.8M—100.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
-0.5%
Avg return
Earnings day
-3.1%
Avg return
5 days after
-10.8%
Avg return
30 days after
42%
15 / 36 earnings
Positive
+70.1%
Q2 2020
Best reaction
-22.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +0.0% | +5.3% | -38.9% | |
| Q3 2025 | -11.1% | -22.4% | -20.0% | |
| Q2 2026 | -4.0% | -8.2% | -13.2% | |
| Q2 2025 | -4.0% | -8.2% | -13.2% | |
| Q1 2025 | -15.1% | -24.6% | -52.6% | |
| Q4 2024 | -15.7% | -22.1% | +14.4% | |
| Q3 2024 | +3.7% | +2.1% | +7.6% | |
| Q2 2024 | +0.0% | +1.0% | -8.6% | |
| Q1 2024 | -12.3% | -5.5% | -0.7% | |
| Q4 2023 | +7.9% | +6.4% | +17.7% | |
| Q3 2023 | +0.7% | -5.6% | -9.8% | |
| Q2 2023 | -6.9% | -6.0% | -21.6% | |
| Q1 2023 | -5.8% | +1.8% | -28.1% | |
| Q4 2022 | -22.4% | -29.9% | -8.6% | |
| Q3 2022 | -5.9% | -11.6% | -48.4% | |
| Q2 2022 | +8.4% | +28.6% | -31.7% | |
| Q1 2022 | -19.5% | -16.3% | -14.0% | |
| Q4 2021 | +3.5% | +0.9% | -7.1% | |
| Q3 2021 | -5.0% | -7.8% | +3.7% | |
| Q2 2021 | -21.8% | -17.4% | -0.3% | |
| Q1 2021 | +15.2% | -9.2% | -19.4% | |
| Q4 2020 | +15.1% | +6.5% | +6.5% | |
| Q3 2020 | +8.1% | +10.2% | -27.6% | |
| Q2 2020 | +70.1% | +71.1% | +54.6% | |
| Q1 2020 | +2.6% | +0.0% | -40.9% | |
| Q4 2019 | -0.7% | -1.4% | -59.7% | |
| Q3 2019 | -9.4% | -11.6% | -11.4% | |
| Q2 2019 | -3.1% | +0.6% | -2.0% | |
| Q1 2019 | +1.8% | +6.5% | -9.7% | |
| Q4 2018 | -12.4% | -21.1% | +7.2% | |
| Q3 2017 | +14.4% | +1.4% | +13.0% | |
| Q3 2018 | +14.4% | +1.4% | +13.0% | |
| Q2 2017 | -1.2% | -10.2% | -22.3% | |
| Q2 2018 | -1.2% | -10.2% | -22.3% | |
| Q1 2018 | -7.7% | -10.1% | -14.3% | |
| Q4 2017 | +2.9% | +5.3% | +18.6% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro